Learn More About Tirzepatide What is Tirzepatide Tirzepatide (brand name Mounjaro for diabetes, Zepbound for weight management) is a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptor agonist the first approved medication to act simultaneously on both incretin hormone receptors
The necessary precautions and measures to make a decision with regards to each case include performing a gastric ultrasound, using rapid sequence induction and intubation, awake intubation, considering measures for emergence, extubation, and even the possibility of deferring the case in elective surgery
Copyright 2023, 2026, Eli Lilly and Company
When adding tirzepatide to existing insulin therapy, consider an initial 10-20% reduction in basal insulin dose, with greater reductions (up to 20-30%) for patients with A1C levels near target
No bad side effects thus far Rated 5 out of 5 Melanie Mitchell (verified owner) The medicine is working but you increased your price and I cant afford it
